Ramelteon (TAK-375) CAS 196597-26-9 Puritas >99.5% (HPLC)

Description:

Nomen chemicum: Ramelteon

Synonyma: TAK-375;Rozerem®

CAS: 196597-26-9

Puritas: >99.5% (HPLC)

Aspectus: Crystallinus Powder Alba

API, Probatus pro Curatio Insomnia

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ducens Manufacturer et Supplier, intermedia Ramelteonis
Ramelteon (TAK-375) CAS 196597-26-9
2,3-Dihydrobenzofuran CAS 496-16-2
1,2,6,7-Tetrahydro-8H-Indeno[5,4-b]furan-8-one CAS 196597-78-1
Ramelteon Acrylonitrile CAS 196597-79-2
Despropionyl Ramelteon Hydrochloridum CAS 196597-80-5
2-(2,6,7,8-Tetrahydro-1H-Indeno[5,4-b]furan-8-yl)ethanamine Hydrochloride CAS 1053239-39-6
Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	Ramelteon
Synonyma	(S)-N-[2-(2,6,7,8-Tetrahydro-1H-Indeno[5,4-b]furan-8-yl)ethyl]propionamide;TAK-375;TAK375;TAK 375;Rozerem
CAS Number	196597-26-9
CATTUS Number	RF2885
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C16H21NO2
M. Pondus	259.35
Liquescens punctum	113.0 ad 116.0℃
Ferveret	455.3±24.0℃
Density	1.119±0.06 g/cm3
Imprimis rotationis [α]20/D	-55.0° ad -60.0° (C=1, CHCL3).
Solubilitas in aqua	Insolubilis in aqua (11 mg/l 25℃)
Solubilitas	Solutum in Ethanol, Methanol, DMSO
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Crystallina pulveris alba
Puritas / Analysis Methodus	>99.5% (HPLC)
Liquescens punctum	113.0~116.0℃
Damnum in Siccatio	<0.50%
Residere in Ignition	<0.10%
Isomer puritas	<0.10%
Metalla gravis	<10ppm
Acorem vel Alkalinity	Conformare
Ethanol	<5000ppm
una immunditia	<0.20%
Totalis immunditias	<0.50%
Infrared Imaginis	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	API, Probatus pro Curatio Insomnia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Applicatio:

Ramelteon (CAS: 196597-26-9) primum ab US Food and Drug Administration (FDA) die 22 Iulii 2005 probatus est, deinde a pharmaceuticis et medicinis machinis Agency (PMDA) die 16 Apr. 2010 probatus est. venales Rozerem® by Takeda,Insomnia vix somnum tractare possunt, et certos effectus habet in insomnia chronica et breve tempus insomnia.Productum hoc selective potest movere genus 1 et typus 2 receptores melatonin (MT1, MT2), augere somnum tardum fluctum (SWS) et motum oculi celeri somnum (REW), inde insomnia reducere.Ramelteamide prima insomnia medicinalis curationis non-addictivae quae sub speciali potestate non est.Hoc productum est receptor melatonin agonist.Magnam affinitatem habet cum receptoribus melatonin MT1 et MT2, et effectum agonisticum specificum et perfectum in receptoribus MT1 et MT2 habet, sed cum receptore MT3 non respondet.Praeterea receptores neuro transmissores ut complexorum GABA receptor non obligat, nec actuosissimum enzymeorum intra certum quendam modum impedit.Ergo potest vitare distractionem medicamentorum GABA consociata (quae causare possunt casus currus, casus et fracturae).etc.) et medicamento PROCLIVITAS et dependentia.Rozerem® praesto est tabula cinematographica ad usum oralem, continens 8 mg gratuiti Ramelteonis.Commendatur adultus dosis 8 mg sumpta intra 30 minuta cubitum iens.